Patents by Inventor Richard E. Stafford
Richard E. Stafford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10272146Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: March 14, 2017Date of Patent: April 30, 2019Assignee: Sanaria Inc.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20170274061Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: ApplicationFiled: March 14, 2017Publication date: September 28, 2017Applicant: Sanaria Inc.Inventors: B. Kim Lee SIM, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Patent number: 9616115Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: January 21, 2016Date of Patent: April 11, 2017Assignee: SANARIA INC.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20160175417Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: ApplicationFiled: January 21, 2016Publication date: June 23, 2016Applicant: Sanaria Inc.Inventors: B. Kim Lee SIM, Minglin LI, Richard E. STAFFORD, Stephen L. HOFFMAN
-
Patent number: 9241982Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: March 27, 2015Date of Patent: January 26, 2016Assignee: SANARIA INC.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20150313981Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: ApplicationFiled: March 27, 2015Publication date: November 5, 2015Applicant: Sanaria Inc.Inventors: B. Kim Lee SIM, Minglin LI, Richard E. STAFFORD, Stephen L. Hoffman
-
Patent number: 8992944Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: December 28, 2012Date of Patent: March 31, 2015Assignee: Sanaria Inc.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Patent number: 8821896Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: December 28, 2012Date of Patent: September 2, 2014Assignee: Sanaria Inc.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20130251750Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: ApplicationFiled: December 28, 2012Publication date: September 26, 2013Applicant: Sanaria Inc.Inventors: B. Kim Lee SIM, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Patent number: 8367810Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: August 27, 2010Date of Patent: February 5, 2013Assignee: Sanaria Inc.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20120058543Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: ApplicationFiled: August 27, 2010Publication date: March 8, 2012Applicant: Sanaria, Inc.Inventors: B. Kim Lee SIM, Minglin Li, Richard E. STAFFORD, Stephen L. HOFFMAN
-
Patent number: 8043625Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: GrantFiled: January 8, 2010Date of Patent: October 25, 2011Assignee: Sanaria Inc.Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20100183680Abstract: Disclosed are substantially purified Plasmodium sporozoites and preparations of Plasmodium sporozoites substantially separated from attendant non-sporozoite material, where the preparations of Plasmodium sporozoites have increasing levels of purity. Vaccines and pharmaceutical compositions comprising purified Plasmodium sporozoites are likewise provided. Methods of purifying preparations of Plasmodium sporozoites are also provided.Type: ApplicationFiled: January 8, 2010Publication date: July 22, 2010Inventors: B. Kim Lee Sim, Minglin Li, Richard E. Stafford, Stephen L. Hoffman
-
Publication number: 20030180181Abstract: Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, spores, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation.Type: ApplicationFiled: April 29, 2002Publication date: September 25, 2003Inventors: Teri Greib, David M. Mann, Richard E. Stafford, Wilson Burgess, William N. Drohan, Martin J. MacPhee
-
Publication number: 20030124080Abstract: The invention provides personal care products that include, within a pressurized can, a personal care formulation, a propellant, and a sorbant that has formed a gel with at least a portion of the propellant. The invention also provides methods of manufacturing personal care products.Type: ApplicationFiled: December 26, 2001Publication date: July 3, 2003Inventors: Antoine Kawam, Richard E. Stafford
-
Patent number: 6231845Abstract: The present invention provides an after shave composition comprising, by weight, 30 to 98%, preferably 65 to 95%, most preferably 70 to 90%, water, 0 to 65%, preferably 0 to 25%, most preferably 10 to 22%, ethanol, 0.25 to 6%, preferably 1 to 5%, fragrance, 0.25 to 5%, preferably 1 to 4%, surfactant to solubilize or emulsify the fragrance, and 0.5 to 1.5% (U.S.P.), preferably 0.8 to 1.3%, aluminum chlorohydrate. Preferably, the composition will be a clear solution or microemulsion having a clarity better than 100 NTU and a viscosity less than 200 mPas. The foregoing composition provides, upon application to the skin, reduced stinging and burning, reduced redness and irritation, and a soothing effect without tackiness or other undesirable aesthetic attributes.Type: GrantFiled: May 24, 1999Date of Patent: May 15, 2001Assignee: The Gillette CompanyInventors: Maureen Sullivan Morrissey, Richard E. Stafford